LOS ALTOS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, a novel medical device start-up based in Silicon Valley, Calif., today announced the formation of its first global medical advisory board (MAB). Fist Assist Devices, LLC has developed the only wearable patent-protected intermittent compression device for vein dilation for patients with end-stage renal […]
Peripheral/Endo
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced that Company management will present at the Cowen and Company 39th Annual Health Care Conference in Boston on Monday, March […]
MIAMI CARDIAC & VASCULAR INSTITUTE BECOMES FIRST IN NORTH AMERICA TO USE NEW ROYAL PHILIPS TECHNOLOGY FOR INTERVENTIONAL PROCEDURES
CORAL GABLES, Fla. – Miami Cardiac & Vascular Institute, the largest and most comprehensive cardiovascular center in the South Florida region, is the first in the United States to use technology it developed, in partnership with Philips, that makes it easier for doctors to perform image guided procedures for heart […]
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial
CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC Davis Health (“UC Davis”) located in Sacramento, California to be the clinical trial site for the Company’s Phase II clinical trial […]
Hancock Jaffe Successfully Starts First-in-Human VenoValve Study
IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today announced the successful start of its VenoValve® first-in-human study in Bogota, Colombia. The first VenoValve was implanted in a patient and the procedure […]
Philips launches Zenition mobile C-arm platform for enhanced operating room performance and workflow efficiency
AMSTERDAM, Feb. 18, 2019 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Zenition, its new mobile C-arm imaging platform. Mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including […]
Affluent Medical Releases Impressive Results from Scope 1 Clinical Trial Validating Efficacy of KARDIOZIS Technology
PARIS–(BUSINESS WIRE)–Affluent Medical (Paris:ALAM), a French medtech company specialized in innovative, minimally invasive implants designed to restore key physiological functions for patients suffering from heart and vascular diseases, as well as urinary incontinence, today announces positive results from its SCOPE 1 clinical trial validating the efficacy of KARDIOZIS technology. Results have been […]
Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device
DUBLIN – February 7, 2019 – Medtronic plc (NYSE:MDT) announced today that it has received U.S. Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline(TM) Flex embolization device.1 Previously indicated for the endovascular treatment of adults with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid […]
VentureMed Group Names J. Robert Paulson Jr. Chief Executive Officer
Toledo, Ohio, February 5, 2019 – VentureMed Group, Inc., a privately-held medical device company that develops and markets the FLEX Vessel Prep™ System to treat peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced today that J. Robert Paulson, Jr., has been appointed president and chief […]
According to THE SAGE GROUP, Thrombus is Highly Prevalent in Both Symptomatic and Asymptomatic Peripheral Artery Disease (PAD) Patients
BEAUFORT, S.C.–(BUSINESS WIRE)–A new analysis published by THE SAGE GROUP concludes that occlusive thrombus is present in 3.6 million PAD patients. “Occlusive thrombus in the leg arteries has serious consequences including ischemic symptoms, and in severe cases amputation. Furthermore, its presence adversely affects interventional procedure outcomes and costs. Thrombus interferes […]



